Clinical management of borderline ovarian tumors

References

• Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am. J. Clin. Pathol.123(Suppl.), S13–S57 (2005).
   Google Scholar
• Taylor HC Jr. Malignant and semi-malignant tumors of the ovary. Surg. Gynecol. Obstet.48, 204–230 (1929).
   Google Scholar
• Tavassoli FA, Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press, Lyon, France (2003).
   Google Scholar
• Lenhard MS, Mitterer S, Kumper C et al. Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort. Eur. J. Obstet. Gynecol. Reprod. Biol.145(2), 189–194 (2009).
   PubMed Web of Science ®Google Scholar
• Skirnisdottir I, Garmo H, Wilander E, Holmberg L. Borderline ovarian tumors in Sweden 1960–2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int. J. Cancer123(8), 1897–1901 (2008).
   PubMed Web of Science ®Google Scholar
• Tinelli R, Tinelli A, Tinelli FG, Cicinelli E, Malvasi A. Conservative surgery for borderline ovarian tumors: a review. Gynecol. Oncol.100(1), 185–191 (2006).
   PubMed Web of Science ®Google Scholar
• Sherman ME, Berman J, Birrer MJ et al. Current challenges and opportunities for research on borderline ovarian tumors. Hum. Pathol.35(8), 961–970 (2004).
   Google Scholar
• Sherman ME, Mink PJ, Curtis R et al. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer100(5), 1045–1052 (2004).
   PubMed Web of Science ®Google Scholar
• Tempfer CB, Polterauer S, Bentz EK, Reinthaller A, Hefler LA. Accuracy of intraoperative frozen section analysis in borderline tumors of the ovary: a retrospective analysis of 96 cases and review of the literature. Gynecol. Oncol.107(2), 248–252 (2007).
   PubMed Web of Science ®Google Scholar
• Hata K, Hata T, Manabe A, Kitao M. Ovarian tumors of low malignant potential: transvaginal Doppler ultrasound features. Gynecol. Oncol.45(3), 259–264 (1992).
   Google Scholar
• Coumbos A, Sehouli J, Chekerov R et al. Clinical management of borderline tumours of the ovary: results of a multicentre survey of 323 clinics in Germany. Br. J. Cancer100(11), 1731–1738 (2009).
   PubMed Web of Science ®Google Scholar
• Cadron I, Leunen K, Van Gorp T, Amant F, Neven P, Vergote I. Management of borderline ovarian neoplasms. J. Clin. Oncol.25(20), 2928–2937 (2007).
   PubMed Web of Science ®Google Scholar
• Baker P, Oliva E. A practical approach to intraoperative consultation in gynecological pathology. Int. J. Gynecol. Pathol.27(3), 353–365 (2008).
   PubMed Web of Science ®Google Scholar
• du Bois A, Ewald-Riegler N, du Bois O, Harter P. Borderline tumors of the ovary – a systematic review [German]. Geburtsh Frauenheilk69, 807–833 (2009).
   Google Scholar
• Gershenson DM. Clinical management potential tumours of low malignancy. Best Pract. Res. Clin. Obstet. Gynaecol.16(4), 513–527 (2002).
   PubMed Web of Science ®Google Scholar
• Heintz AP, Odicino F, Maisonneuve P et al. Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int. J. Gynaecol. Obstet.95(Suppl. 1), S161–S192 (2006).
   Web of Science ®Google Scholar
• Cadron I, Amant F, Van Gorp T, Neven P, Leunen K, Vergote I. The management of borderline tumours of the ovary. Curr. Opin. Oncol.18(5), 488–493 (2006).
   PubMed Web of Science ®Google Scholar
• Bostwick DG, Tazelaar HD, Ballon SC, Hendrickson MR, Kempson RL. Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases. Cancer58(9), 2052–2065 (1986).
   PubMed Web of Science ®Google Scholar
• Hart WR. Borderline epithelial tumors of the ovary. Mod. Pathol.18(Suppl. 2), S33–S50 (2005).
   PubMed Web of Science ®Google Scholar
• Seidman JD, Soslow RA, Vang R et al. Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum. Pathol.35(8), 918–933 (2004).
   PubMedGoogle Scholar
• Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer62(10), 2212–2222 (1988).
   PubMed Web of Science ®Google Scholar
• Bell KA, Smith Sehdev AE, Kurman RJ. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am. J. Surg. Pathol.25(4), 419–432 (2001).
   PubMed Web of Science ®Google Scholar
• Seidman JD, Horkayne-Szakaly I, Haiba M, Boice CR, Kurman RJ, Ronnett BM. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int. J. Gynecol. Pathol.23(1), 41–44 (2004).
   PubMed Web of Science ®Google Scholar
• Stewart CJ, Brennan BA, Hammond IG, Leung YC, McCartney AJ, Ruba S. Intraoperative assessment of clear cell carcinoma of the ovary. Int. J. Gynecol. Pathol.27(4), 475–482 (2008).
   Google Scholar
• Ren J, Peng Z, Yang K. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors. Gynecol. Oncol.110(2), 162–167 (2008).
   PubMed Web of Science ®Google Scholar
• Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am. J. Surg. Pathol.20(11), 1319–1330 (1996).
   PubMed Web of Science ®Google Scholar
• Silva EG, Gershenson DM, Malpica A, Deavers M. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Am. J. Surg. Pathol.30(11), 1367–1371 (2006).
   PubMed Web of Science ®Google Scholar
• Prat J, De Nictolis M. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am. J. Surg. Pathol.26(9), 1111–1128 (2002).
   PubMed Web of Science ®Google Scholar
• Chang SJ, Ryu HS, Chang KH, Yoo SC, Yoon JH. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors. Acta Obstet. Gynecol. Scand.87(4), 476–481 (2008).
   PubMed Web of Science ®Google Scholar
• Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum. Pathol.31(5), 539–557 (2000).
   PubMed Web of Science ®Google Scholar
• Kane A, Uzan C, Rey A et al. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants. Oncologist14(6), 591–600 (2009).
   PubMed Web of Science ®Google Scholar
• Silverberg SG, Bell DA, Kurman RJ et al. Borderline ovarian tumors: key points and workshop summary. Hum. Pathol.35(8), 910–917 (2004).
   Google Scholar
• Buttin BM, Herzog TJ, Powell MA, Rader JS, Mutch DG. Epithelial ovarian tumors of low malignant potential: the role of microinvasion. Obstet. Gynecol.99(1), 11–17 (2002).
   Google Scholar
• Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up. Am. J. Surg. Pathol.29(6), 707–723 (2005).
   PubMed Web of Science ®Google Scholar
• Cusido M, Balaguero L, Hernandez G et al. Results of the national survey of borderline ovarian tumors in Spain. Gynecol. Oncol.104(3), 617–622 (2007).
   PubMed Web of Science ®Google Scholar
• Smith Sehdev AE, Sehdev PS, Kurman RJ. Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases. Am. J. Surg. Pathol.27(6), 725–736 (2003).
   Google Scholar
• Palomba S, Zupi E, Russo T et al. Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study. Hum. Reprod.22(2), 578–585 (2007).
   Google Scholar
• Morice P, Camatte S, Rey A et al. Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. Ann. Oncol.14(4), 592–598 (2003).
   PubMed Web of Science ®Google Scholar
• Kaern J, Trope CG, Kristensen GB, Abeler VM, Pettersen EO. DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary. Int. J. Gynecol. Cancer3(6), 349–358 (1993).
   PubMedGoogle Scholar
• Yokoyama Y, Moriya T, Takano T et al. Clinical outcome and risk factors for recurrence in borderline ovarian tumours. Br. J. Cancer94(11), 1586–1591 (2006).
   Google Scholar
• Meyer JS, Gersell DJ, Yim S. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate. Gynecol. Oncol.81(3), 466–476 (2001).
   Google Scholar
• Verbruggen MB, van Diest PJ, Baak JP, Broeckaert MA, Kenemans P, Verheijen RH. The prognostic and clinical value of morphometry and DNA cytometry in borderline ovarian tumors: a prospective study. Int. J. Gynecol. Pathol.28(1), 35–40 (2009).
   Google Scholar
• Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int. J. Gynaecol. Obstet.70(2), 209–262 (2000).
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim TJ, Park YG et al. Clinical analysis of intra-operative frozen section proven borderline tumors of the ovary. J. Gynecol. Oncol.20(3), 176–180 (2009).
   PubMed Web of Science ®Google Scholar
• Brun JL, Cortez A, Rouzier R et al. Factors influencing the use and accuracy of frozen section diagnosis of epithelial ovarian tumors. Am. J. Obstet. Gynecol.199(3), 244 E241–E247 (2008).
   Google Scholar
• Menzin AW, Gal D, Lovecchio JL. Contemporary surgical management of borderline ovarian tumors: a survey of the Society of Gynecologic Oncologists. Gynecol. Oncol.78(1), 7–9 (2000).
   PubMed Web of Science ®Google Scholar
• Schmalfeldt B, Pfisterer J. Interdisziplinäre S2k-Leitlinie für die Diagnostik und Therapie malginer Ovarialtumoren. Verlag, Z (Ed.). Germany (2007).
   Google Scholar
• Trope CG, Kristensen G, Makar A. Surgery for borderline tumor of the ovary. Semin. Surg. Oncol.19(1), 69–75 (2000).
   PubMedGoogle Scholar
• Fauvet R, Boccara J, Dufournet C, David-Montefiore E, Poncelet C, Darai E. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study. Cancer100(6), 1145–1151 (2004).
   PubMed Web of Science ®Google Scholar
• Kurman RJ, Seidman JD, Shih IM. Serous borderline tumours of the ovary. Histopathology47(3), 310–315 (2005).
   Google Scholar
• McKenney JK, Balzer BL, Longacre TA. Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification. Am. J. Surg. Pathol.30(5), 614–624 (2006).
   Google Scholar
• Fadare O. Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors). Int. J. Gynecol. Cancer19(1), 103–108 (2009).
   Google Scholar
• Camatte S, Morice P, Thoury A et al. Impact of surgical staging in patients with macroscopic ‘stage I’ ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur. J. Cancer40(12), 1842–1849 (2004).
   Google Scholar
• Desfeux P, Camatte S, Chatellier G, Blanc B, Querleu D, Lecuru F. Impact of surgical approach on the management of macroscopic early ovarian borderline tumors. Gynecol. Oncol.98(3), 390–395 (2005).
   PubMed Web of Science ®Google Scholar
• Morice P. Borderline tumours of the ovary and fertility. Eur. J. Cancer42(2), 149–158 (2006).
   PubMed Web of Science ®Google Scholar
• Suh-Burgmann E. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecol. Oncol.103(3), 841–847 (2006).
   PubMed Web of Science ®Google Scholar
• Chan JK, Lin YG, Loizzi V, Ghobriel M, DiSaia PJ, Berman ML. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome. J. Reprod. Med.48(10), 756–760 (2003).
   Google Scholar
• Morice P, Camatte S, El Hassan J, Pautier P, Duvillard P, Castaigne D. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil. Steril.75(1), 92–96 (2001).
   PubMed Web of Science ®Google Scholar
• Romagnolo C, Gadducci A, Sartori E, Zola P, Maggino T. Management of borderline ovarian tumors: results of an Italian multicenter study. Gynecol. Oncol.101(2), 255–260 (2006).
   Google Scholar
• Beiner ME, Gotlieb WH, Davidson B, Kopolovic J, Ben-Baruch G. Infertility treatment after conservative management of borderline ovarian tumors. Cancer92(2), 320–325 (2001).
   PubMed Web of Science ®Google Scholar
• Seracchioli R, Venturoli S, Colombo FM, Govoni F, Missiroli S, Bagnoli A. Fertility and tumor recurrence rate after conservative laparoscopic management of young women with early-stage borderline ovarian tumors. Fertil. Steril.76(5), 999–1004 (2001).
   Google Scholar
• Yinon Y, Beiner ME, Gotlieb WH, Korach Y, Perri T, Ben-Baruch G. Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors. Fertil. Steril.88(2), 479–484 (2007).
   Google Scholar
• Marcickiewicz J, Brannstrom M. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence. Acta Obstet. Gynecol. Scand.85(12), 1496–1500 (2006).
   PubMed Web of Science ®Google Scholar
• Poncelet C, Fauvet R, Boccara J, Darai E. Recurrence after cystectomy for borderline ovarian tumors: results of a French multicenter study. Ann. Surg. Oncol.13(4), 565–571 (2006).
   Google Scholar
• Salomon LJ, Lhomme C, Pautier P, Duvillard P, Morice P. Safety of simple cystectomy in patients with unilateral mucinous borderline tumors. Fertil. Steril.85(5), 1510 e1511–e1514 (2006).
   Google Scholar
• Zanetta G, Rota S, Lissoni A, Meni A, Brancatelli G, Buda A. Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors. Gynecol. Oncol.81(1), 63–66 (2001).
   Google Scholar
• Jung SE, Lee JM, Rha SE, Byun JY, Jung JI, Hahn ST. CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. Radiographics22(6), 1305–1325 (2002).
   PubMed Web of Science ®Google Scholar
• Fauvet R, Boccara J, Dufournet C, Poncelet C, Darai E. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. Ann. Oncol.16(3), 403–410 (2005).
   PubMed Web of Science ®Google Scholar
• Odegaard E, Staff AC, Langebrekke A, Engh V, Onsrud M. Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy. Acta Obstet. Gynecol. Scand.86(5), 620–626 (2007).
   PubMed Web of Science ®Google Scholar
• Deffieux X, Morice P, Camatte S, Fourchotte V, Duvillard P, Castaigne D. Results after laparoscopic management of serous borderline tumor of the ovary with peritoneal implants. Gynecol. Oncol.97(1), 84–89 (2005).
   Google Scholar
• De Iaco P, Ferrero A, Rosati F et al. Behaviour of ovarian tumors of low malignant potential treated with conservative surgery. Eur. J. Surg. Oncol.35(6), 643–648 (2009).
   PubMed Web of Science ®Google Scholar
• Trope C, Kaern J, Vergote IB, Kristensen G, Abeler V. Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors. Gynecol. Oncol.51(2), 236–243 (1993).
   PubMed Web of Science ®Google Scholar
• Sieben NL, Roemen GM, Oosting J, Fleuren GJ, van Engeland M, Prat J. Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implants. J. Pathol.210(4), 405–411 (2006).
   Google Scholar
• Ayhan A, Guvendag Guven ES, Guven S, Kucukali T. Recurrence and prognostic factors in borderline ovarian tumors. Gynecol. Oncol.98(3), 439–445 (2005).
   PubMed Web of Science ®Google Scholar
• Mantzavinos T, Kanakas N, Genatas C, Papadias K, Zourlas PA. Five years’ follow-up in two patients with borderline tumours of the ovary hyperstimulated by gonadotrophin therapy for in-vitro fertilization. Hum. Reprod.9(11), 2032–2033 (1994).
   Google Scholar
• Ortiz BH, Ailawadi M, Colitti C et al. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res.61(19), 7264–7267 (2001).
   Google Scholar
• Parker RL, Clement PB, Chercover DJ, Sornarajah T, Gilks CB. Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: a report of two cases. Int. J. Gynecol. Pathol.23(3), 265–272 (2004).
   Web of Science ®Google Scholar
• Kurman RJ, Shih Ie M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int. J. Gynecol. Pathol.27(2), 151–160 (2008).
   PubMed Web of Science ®Google Scholar
• Levanon K, Crum C, Drapkin R. New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J. Clin. Oncol.26(32), 5284–5293 (2008).
   PubMed Web of Science ®Google Scholar
• Kurman RJ, Visvanathan K, Roden R, Wu TC, Shih Ie M. Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am. J. Obstet. Gynecol.198(4), 351–356 (2008).
   PubMed Web of Science ®Google Scholar
• Meinhold-Heerlein I, Bauerschlag D, Hilpert F et al. Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential. Oncogene24(6), 1053–1065 (2005).
   PubMedGoogle Scholar
• Bonome T, Lee JY, Park DC et al. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer Res.65(22), 10602–10612 (2005).
   PubMed Web of Science ®Google Scholar
• Mahner S, Baasch C, Schwarz J et al.C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma. Br. J. Cancer99(8), 1269–1275 (2008).
   PubMed Web of Science ®Google Scholar
• Plaxe SC. Epidemiology of low-grade serous ovarian cancer. Am. J. Obstet. Gynecol.198(4), 459 E451–E458 (2008).
   Google Scholar